The company's net debt jumped from NZD 14.5 million to NZD 38.6 million as it aggressively funded its expansion into South Africa and other global regions. Despite the rising debt levels, the 2026 fiscal year proved to be a landmark period for AFT Pharmaceuticals as it effectively balanced capital
Chronic disease management has historically prioritized pharmaceutical intervention over dietary modification, but a shift toward preventative nutrition is finally gaining significant traction across the mainstream medical landscape. The Office of Food Systems Resilience is funding six multi-sector
Citius Pharmaceuticals is leveraging a staggering 86 percent overall response rate from Phase 1 trials of LYMPHIR as a pretreatment for CAR-T therapy in large B-cell lymphoma. This clinical success arrives at a pivotal moment as the company navigates the complex transition from a research-oriented
Medical device seizures and withdrawals are often caused by preventable labeling errors, making senior-level regulatory judgment an essential part of the compliance process. The transition from the old regulatory framework to the current European Union Medical Device Regulation (EU MDR) has
In the remote reaches of Ghana's northern territories, the distinct hum of autonomous medical drones has transitioned from a novel experiment to a life-saving heartbeat of the national healthcare system. This technological evolution marks a significant departure from traditional logistical hurdles
The intricate machinery of the American healthcare supply chain is currently undergoing a massive transformation as it scales to meet the needs of a rapidly aging and medically complex population. This sector, often operating behind the scenes, acts as the indispensable bridge between global
